Startup Monod Bio Inc. has secured $25 million in seed financing to develop a new technology designed to speed disease detection and help physicians manage patients with chronic conditions. Seattle-based Monod is developing an instrument that could be used for diagnostic applications at the point of care.
top of page
bottom of page